Form 8-K - Current report:
SEC Accession No. 0001493152-25-011152
Filing Date
2025-03-21
Accepted
2025-03-21 16:20:34
Documents
22
Period of Report
2025-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45450
2 ex10-1.htm EX-10.1 4467
3 ex99-1.htm EX-99.1 29879
4 ex10-1_001.jpg GRAPHIC 491531
5 ex10-1_002.jpg GRAPHIC 659162
6 ex10-1_003.jpg GRAPHIC 635491
7 ex10-1_004.jpg GRAPHIC 566667
8 ex10-1_005.jpg GRAPHIC 215202
9 ex10-1_006.jpg GRAPHIC 144266
10 ex10-1_007.jpg GRAPHIC 68089
  Complete submission text file 0001493152-25-011152.txt   4093660

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE meds-20250317.xsd EX-101.SCH 3009
12 XBRL LABEL FILE meds-20250317_lab.xml EX-101.LAB 34240
13 XBRL PRESENTATION FILE meds-20250317_pre.xml EX-101.PRE 22355
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3687
Mailing Address 2420 BRUNELLO TRACE LUTZ FL 33558
Business Address 2420 BRUNELLO TRACE LUTZ FL 33558 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39199 | Film No.: 25760773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)